About this episode

This episode discusses the updated KDIGO guidelines on managing iron deficiency in patients with chronic kidney disease, focusing on IV iron replacement therapy.

Faculty: Brendon Neuen, MBBS, PhD Recent updates to the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD) emphasized the expanded role of IV iron replacement therapy in patients with non–dialysis-dependent CKD. The updated guidance emphasizes proactive iron assessment, earlier identification of iron deficiency phenotypes, and individualized selection of iron replacement strategies to improve long-term patient outcomes. Other updates include reclassification of systemic iron deficiency and iron-restricted anemia, plus screening recommendations for iron deficiency and iron-deficient anemia.

People in this episode

Guest: Brendon Neuen, MBBS, PhD

Topics covered

• iron deficiency
• CKD
• IV iron replacement therapy
• KDIGO guidelines
• anemia management

Keywords

• iron deficiency
• CKD
• IV iron therapy
• KDIGO guidelines
• anemia
• iron assessment
• patient outcomes

Mentioned in this episode

Organizations: KDIGO, Chronic Kidney Disease

Explore listener stats, chart rankings, contacts and more on the CME podcast page.